Production

Pharma

Dispensaries

Investors

Sales and Operations

Consumer

Events and Networking

Politics and Law

Production

Pharma

Dispensaries

Investors

Sales and Operations

Consumer

Events and Networking

Politics and Law

Featured Articles

Featured Articles

Hemp Industry Experts Say Regulations Would Boost Sector

Hemp Industry Experts Say Regulations Would Boost Sector

For nearly a century, hemp has been at the mercy of prohibitionist policies that outlawed the cultivation and sale of industrial hemp in America. But after the 2018 Farm Bill legalized hemp and allowed states that were interested to create hemp programs, a robust industry quickly grew around the plant. By the end of 2020, the U.S. hemp industry had generated nearly $10 billion in sales, partly due to the rising popularity of cannabidiol (“CBD”), a hemp extract said to have potent medical properties. However, the industry is barely regulated by the federal government. Each state has its own rules, leading to a patchwork of hemp regulations across the country, and the relevant authorities still haven’t created a comprehensive regulatory structure for hemp. Stakeholders and lawmakers have urged the U.S. Food and Drug Administration (“FDA”) to craft hemp regulations, but the federal agency has been dragging its feet. In the wake of the FDA’s rejection of a proposal to allow the sale of full-spectrum CBD as a dietary supplement, industry leaders say hemp would benefit a great deal from regulation. Priyanka Sharma, cofounder of Kazmira, a Denver-based, industrial-scale producer of CBD isolate, says that regulation would raise the bar for high-quality production and manufacturing processes and ensure customers get products with safe ingredients. FDA approval would also provide sellers with the most-effective product format, Sharma says, allowing for much-needed toxicology and safety studies on hemp extracts such as CBD. According to Jeniffer Knaack, the senior director of compliance and science at Koi CBD in California, hemp products deserve just as much legitimacy as other botanical supplements. Federal prohibitionist policies against cannabis and hemp have created significant barriers to research, commerce, and investment, she says.

CannabisNewsWire, 09/23/2021 04:20:00

Open article: https://www.cannabisnewswire.com/hemp-industry-experts-say-regulations-would-boost-sector/

read more
Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with “Project Change Lives”

Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with “Project Change Lives”

For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their therapeutic and medicinal abilities. Scientists have identified at least 113 different chemicals in the plant — with tetrahydrocannabinol (THC) and cannabidiol (CBD) — known for treating epilepsy, multiple sclerosis, chronic pain, chemotherapy-induced nausea, HIV complications, and a variety of other chronic disease states. Studies have shown that cannabinoids may be beneficial in fighting cancer, while chemicals found in the cannabis plant are also under investigation as possible treatments for immune system diseases, including HIV/AIDS, multiple sclerosis (MS), and lupus. Considering the potential benefits that can be derived from cannabinoids, experts have called for more research to harness its full potential. However, there certainly have been roadblocks to this. Apart from the lack of available funds and pharmaceutical-grade cannabinoids to support high-quality research, another barrier is the U.S. Drug Enforcement Administration’s (DEA) decision to categorize marijuana as a Schedule I drug — the same as heroin, ecstasy, and LSD. Due to this classification by the DEA, researchers and institutions need a special license to study, develop, and harness the possibly enormous untapped benefits of cannabinoids. To help advance research and also help tap into the full benefits of cannabinoids, Clever Leaves (NASDAQ: CLVR), a multinational cannabis company, has launched Project Change Lives to make that dream a reality. The company, which emphasizes ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabis business, is hoping to leverage the Project Change Lives initiative to cause a paradigm shift and advance domestic research into cannabinoids.

420 Intel – Marijuana Industry News, 09/22/2021 20:00:00

Open article: https://420intel.com/articles/2021/09/23/clever-leaves-advancing-research-cannabis-chronic-disease-treatment-project

read more
Prospect of federal marijuana legalization doesn’t have everyone in Michigan industry jumping for joy

Prospect of federal marijuana legalization doesn’t have everyone in Michigan industry jumping for joy

One thing most people agree on: Federal marijuana legalization is coming. It’s just a matter of when — and how it will impact existing state markets, such as the one currently growing in Michigan. With the inconsistent patchwork of state laws across the nation regarding medical and recreational marijuana, the implications of federal legalization, accompanied by new taxes, is creating some anxiety. “Opening up interstate commerce would destroy Michigan’s cannabis industry and leave us with nothing but multi-state operators to purchase from,” said Rick Thompson, a Michigan cannabis pioneer and director of the Michigan chapter of the National Organization for the Reform of Marijuana Laws (NORML). Thompson said everyone he knows “stands in opposition to at least some of the” current version of the proposed federal legalization plan. Some of the worry centers on marijuana surpluses in Canada and other states, like Oregon, where producers would benefit greatly from the ability to dump cheap products into the Michigan market, undercutting existing businesses along the way.

420 Intel – Marijuana Industry News, 09/23/2021 20:00:00

Open article: https://420intel.com/articles/2021/09/24/prospect-federal-marijuana-legalization-doesn%E2%80%99t-have-everyone-michigan-industry

read more
New York Marijuana Regulatory Board Is Officially Completed With Governor’s Final Appointments

New York Marijuana Regulatory Board Is Officially Completed With Governor’s Final Appointments

New York Gov. Kathy Hochul (D) on Wednesday announced her final two appointees to regulate the state’s adult-use marijuana market—a key step toward implementing the legalization law signed by her predecessor. Hochul named two additional Cannabis Control Board members weeks after the Senate confirmed previous appointees earlier this month. The newly named regulators—Reuben McDaniel III of the Dormitory Authority of the State of New York and Jessica García of the Retail, Wholesale, and Department Store Union—do not require confirmation by lawmakers. “New York’s cannabis industry has stalled for far too long—I am making important appointments to set the Office of Cannabis Management up for success so they can hit the ground running,” the governor said in a press release. “I am confident Mr. McDaniel and Ms. Garcia will serve the board with professionalism and experience as we lead our state forward in this new industry.” Hochul, who replaced former Gov. Andrew Cuomo (D) last month after he resigned amid a sexual harassment scandal, has been supportive of the legislature’s passage of the adult-use legalization bill this year. And while her predecessor faced criticism as negotiations with legislators on potential appointments stalled, Hochul has now taken the helm and is working with leaders on how to move the process forward.

Kyle Jaeger, Marijuana Moment, 09/22/2021 15:59:00

Open article: https://www.marijuanamoment.net/new-york-marijuana-regulatory-board-is-officially-completed-with-governors-final-appointments/

read more
Mississippi Agriculture Department Should Have No Role In Medical Marijuana Regulation, Commissioner Tells Lawmakers

Mississippi Agriculture Department Should Have No Role In Medical Marijuana Regulation, Commissioner Tells Lawmakers

The commissioner of Mississippi’s Agriculture and Commerce department really doesn’t want to be responsible for overseeing a medical marijuana program—and he reiterated as much in a letter to lawmakers on Thursday. Commissioner Andy Gipson (R) says that as long as cannabis remains federally illegal, he has no interest in having the department assume a regulatory role for any medical marijuana program that legislators enact. The legislature has been working to develop a system after the state Supreme Court overturned a voter-approved reform initiative in May. Gipson similarly wrote a letter to the state attorney general last month to express his opposition to having the department regulate medical marijuana, and he followed up to say the same in the new letter to legislators. “Notwithstanding what you may have been told or what may be represented in the future, I want you to know I remain adamantly opposed to the Mississippi Department of Agriculture and Commerce having any role in regulating medical marijuana so long as marijuana remains a prohibited Schedule I Controlled Substance under State and/or Federal law,” the commissioner said.“Depending on the wording of the bill (a draft of which I have yet to be provided), not only would this proposal require me to violate my oath of office, but it also would fly in the face of the majority of voters who passed Initiative 65 with no regulatory role for the Mississippi Department of Agriculture and Commerce,” he continued.

Kyle Jaeger, Marijuana Moment, 09/23/2021 10:58:00

Open article: https://www.marijuanamoment.net/mississippi-agriculture-department-should-have-no-role-in-medical-marijuana-regulation-commissioner-tells-lawmakers/

read more
Marijuana Banking Sponsor Discusses Path Through Senate After House Approves Reform For Fifth Time

Marijuana Banking Sponsor Discusses Path Through Senate After House Approves Reform For Fifth Time

Tuesday marked the fifth time that the U.S. House of Representatives has passed legislation to protect banks that work with state-legal marijuana businesses. And the lead sponsor of that reform, Rep. Ed Perlmutter (D-CO), tells Marijuana Moment that he does think “the fifth time is the charm” to finally get the measure through the Senate and onto the president’s desk. The Secure and Fair Enforcement (SAFE) Banking Act has previously passed as standalone bills and as provisions tucked into broader bills. On Tuesday, the House attached it to large-scale defense spending legislation in a voice vote, raising hopes that the must-pass National Defense Authorization Act (NDAA) could be a vehicle to actually advance cannabis banking reform into law. In a phone interview on Wednesday, Perlmutter spoke to Marijuana Moment about next steps for the legislation, the barriers that need to be overcome and even joked about how to spell “superfluous,” a term that some members said this week might apply to a marijuana banking amendment in the context of defense spending legislation.

Kyle Jaeger, Marijuana Moment, 09/22/2021 17:58:00

Open article: https://www.marijuanamoment.net/marijuana-banking-sponsor-discusses-path-through-senate-after-house-approves-reform-for-fifth-time/

read more

Join Our Mailing List

Older Posts

All Categories

Production

Consumer

Pharma

Events and Networking

Dispensaries

Politics and Law

Sales and Operations

Investors

View all categories

The Indica Perspective

Always the latest news you need.

Indica News brings you all the latest information from the cannabis world. Sign up today for the latest news.

Advertisement

Indica News

(833) 769-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM

Follow Us

Indica News

(833) 450-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM

Follow Us

Indica News

(833) 450-9333

info@indica.news

}

Monday - Friday: 8:00 AM - 5:00 PM